🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Modern #ClinicalTrial studies are being built with multiple endpoints and objectives, modifications, treatment arms, and dose selections in mind. PPD explores how these complex protocols provide flexible, adaptive approaches. ow.ly/y1Me50QiqNV

Real-world technology is transforming cancer research, making way for more efficient and effective studies. Medrio details how these solutions are boosting operations, from narrowing patient selection to targeting specific biomarkers. bit.ly/3GIoDvY

Life sciences companies can find important partnerships with patient organizations. IQVIA explores the ways these groups improve the lives of patients and their loved ones. Read this report on their roles, activities, and dynamics. bit.ly/3GIGZx0

Global healthcare is being impacted by #ClimateChange, and the #ClinicalTrial world is similarly being transformed. IQVIA shares ways that organizations can support mitigation strategies and lower their carbon footprints. bit.ly/3RpnBKe

Startup activities in #ClinicalTrial work are evolving with the changing technology of the industry. @Advarra explores the potential burdens these shifts could cause for research groups and what teams can do to ease the process. Read more: bit.ly/48otdez

It's not enough for a #ClinicalTrial team to reach regulatory compliance. They must strive for regulatory excellence, fostering an environment of harmony and collaboration. Syneos Health provides tips on how you can get there. bit.ly/3NAmsP3

Medical device development is a demanding and time-sensitive process, making "rescue" or "transition" steps sometimes necessary to keep the delivery of research on target. Fortrea explains the benefits of a CRO dedicated to these devices. bit.ly/3NWTo4v

#ClinicalTrial teams can streamline research processes, improve accuracy and data accessibility, and provide space for collaboration by relying on electronic logs. Florence Healthcare details five options for leveraging these eLogs. bit.ly/3RnpKWQ

#ClinicalTrial organizations of varying sizes are taking different approaches to the advancements in drug development and research. PPD explains the results of their recent survey, with insights on outsourcing, recruitment, and more. bit.ly/3Rngulm

Drug shortages have increased across the U.S. IQVIA assesses current shortages, related manufacturers, and market concentrations — and then considers the causes and impacts of these situations. Read their report: bit.ly/3NH5DSn

Type 2 diabetes impacts 529 million people across 203 countries, and that number is only expected to grow. Fortrea considers how #ClinicalTrial teams can tackle this competitive landscape in Asia Pacific nations. Read some suggested strategies: ow.ly/EY9w50QlgSL

Decentralized #ClinicalTrials can significantly ease common research burdens for patients, and studies around cardiovascular health can also benefit from these practices. ICON Plc shares four key strategies that can improve patient connection. ow.ly/kAgL50QlgTo

The product portfolio of a #biopharma group is often split between assets backed by significant resources and ones that are less supported. Syneos Health shares one way to maintain and grow those less-supported assets: partnerships. Read more: ow.ly/aWnz50QlgUt

It's a new year and new opportunity to stay up to date on thought leadership in the #ClinicalTrial industry! Sign up for our newsletter to have the latest news delivered straight to your inbox: bit.ly/2ZhUGMu

Gaining treatment through cross-border #ClinicalTrials can be challenging for patients with life-impacting diseases. ICON Plc's latest blog shares how sponsors, ethics committees, and regulatory bodies can work together to overcome these barriers. ow.ly/Wmvh50Qlh2e

Massive change came to the #ClinicalTrial industry during 2023, and 2024 is likely to bring just as much growth. Experts shared their expectations for the coming year with PPD. Here are five of their predictions: bit.ly/3tu1BWB

Patient access to minimally invasive cardiovascular devices that can provide life-saving treatment is not equal. Fortrea discusses how #ClinicalTrials can reach diverse populations to improve healthcare access for all. ow.ly/8z4e50QlsLR

Automation in #ClinicalTrials brings both opportunity and challenges, so Syneos Health asked experts about their perspectives on #AI and #MachineLearning. Read their thoughts on tech advancement and the balanced use of these tools. ow.ly/9ghk50QlsOr

Responding to infectious disease outbreaks requires careful disease surveillance and reporting — and these practices are also essential to #vaccine development. ICON Plc shares potential strategies and options for overcoming barriers. ow.ly/juju50QlsR9

Recruiting and retaining patients has a tremendous effect on how a #ClinicalTrial moves forward, and financial burdens can limit patient availability. Watch experts talk with Parexel about how to improve patient engagement and experience. bit.ly/47hJzF6